These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15280456)

  • 61. Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors.
    Tien C; Huang L; Watanabe SM; Speidel JT; Carter CA; Chen C
    PLoS One; 2018; 13(1):e0191372. PubMed ID: 29338056
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
    Counts CJ; Ho PS; Donlin MJ; Tavis JE; Chen C
    PLoS One; 2015; 10(4):e0123561. PubMed ID: 25893662
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
    Kaplan AH; Swanstrom R
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4528-32. PubMed ID: 2034693
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Organization of HIV-1 pol is critical for Pol polyprotein processing.
    Chang YY; Yu SL; Syu WJ
    J Biomed Sci; 1999; 6(5):333-41. PubMed ID: 10494040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.
    Kräusslich HG; Schneider H; Zybarth G; Carter CA; Wimmer E
    J Virol; 1988 Nov; 62(11):4393-7. PubMed ID: 3050149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutational analysis of a native substrate of the HIV-1 proteinase.
    Partin K; Wimmer E; Carter C
    Adv Exp Med Biol; 1991; 306():503-6. PubMed ID: 1667451
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Moloney murine leukemia virus protease expressed in bacteria is enzymatically active.
    Cannon K; Qin L; Schumann G; Boeke JD
    Arch Virol; 1998; 143(2):381-8. PubMed ID: 9541621
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism.
    Louis JM; Wondrak EM; Kimmel AR; Wingfield PT; Nashed NT
    J Biol Chem; 1999 Aug; 274(33):23437-42. PubMed ID: 10438521
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.
    Huang L; Sayer JM; Swinford M; Louis JM; Chen C
    J Virol; 2009 Aug; 83(15):7789-93. PubMed ID: 19457992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation.
    Wondrak EM; Nashed NT; Haber MT; Jerina DM; Louis JM
    J Biol Chem; 1996 Feb; 271(8):4477-81. PubMed ID: 8626801
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
    Potempa M; Nalivaika E; Ragland D; Lee SK; Schiffer CA; Swanstrom R
    J Mol Biol; 2015 Jul; 427(14):2360-78. PubMed ID: 25986307
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of dissociative inhibition of HIV protease and its autoprocessing from a precursor.
    Sayer JM; Aniana A; Louis JM
    J Mol Biol; 2012 Sep; 422(2):230-44. PubMed ID: 22659320
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kinetic characterization of the critical step in HIV-1 protease maturation.
    Sadiq SK; Noé F; De Fabritiis G
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20449-54. PubMed ID: 23184967
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation.
    Kräusslich HG
    J Virol; 1992 Jan; 66(1):567-72. PubMed ID: 1727499
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity.
    Kräusslich HG
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3213-7. PubMed ID: 2014242
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Beyond Inhibition: A Novel Strategy of Targeting HIV-1 Protease to Eliminate Viral Reservoirs.
    Kim JG; Shan L
    Viruses; 2022 May; 14(6):. PubMed ID: 35746649
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The initial step in human immunodeficiency virus type 1 GagProPol processing can be regulated by reversible oxidation.
    Daniels SI; Davis DA; Soule EE; Stahl SJ; Tebbs IR; Wingfield P; Yarchoan R
    PLoS One; 2010 Oct; 5(10):e13595. PubMed ID: 21042582
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cellular Targets of HIV-1 Protease: Just the Tip of the Iceberg?
    Centazzo M; Manganaro L; Alvisi G
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992421
    [TBL] [Abstract][Full Text] [Related]  

  • 79. FRET analysis of HIV-1 Gag and GagPol interactions.
    Takagi S; Momose F; Morikawa Y
    FEBS Open Bio; 2017 Nov; 7(11):1815-1825. PubMed ID: 29123989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nanopore detects γ-radiation inhibited HIV-1 protease activity.
    Li M; Li W; Xiao Y; Liu Q; Liang L; Wang D; Huang W; Wang L
    Biosens Bioelectron; 2021 Dec; 194():113602. PubMed ID: 34481241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.